Marek Jerzy Dąbrowski

Prof. Dr. Marek Jerzy Dąbrowski

1. Medical Faculty, Lazarski University in Warsaw, 02-662 Warsaw, Poland
+1
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
EDEwelina A. Dziedzic
Ewelina A. Dziedzic
Jakub S. GąsiorJakub S. Gąsior
Jakub S. Gąsior
ATAgnieszka Tuzimek
Agnieszka Tuzimek
JPJustyna Paleczny
Justyna Paleczny
Adam JunkaAdam Junka
Adam Junka
PJPiotr Jankowski
Piotr Jankowski
Atherosclerosis, the underlying cause of coronary artery disease (CAD), has a significant inflammatory component. White blood cell count is an affordable and accessible way to assess the systemic immune response, as it comprises many subgroups with distinct and complex functions. Considering their multidirectional effect on atherosclerosis, new biomarkers integrating various leukocyte subgroups, the Systemic Inflammatory Index (SII) and the Systemic Inflammatory Response Index (SIRI), were recently devised to describe the balance between inflammation and immune reaction. This research aimed to evaluate the relationship of the intensity of inflammation measured by these biomarkers with the severity of CAD assessed with coronary angiography and with the diagnosis of acute coronary syndrome (ACS) or stable CAD in 699 patients. SIRI, but not SII, was associated with the diagnosis, having the highest values for patients with ACS (STEMI), significantly higher than in patients with stable CAD (p < 0.01). The highest SII and SIRI values were observed in patients with three-vessel CAD. SII and SIRI require further in-depth and well-designed research to evaluate their potential in a clinical setting.

1 January 2016 in Archives of Medical Science
Verified
Journal Article
Open access
EDEwelina A. Dziedzic
Ewelina A. Dziedzic
SPSebastian Przychodzeń
Sebastian Przychodzeń
MDMarek Jerzy Dąbrowski
Marek Jerzy Dąbrowski
Introduction : A deficiency of 25-hydroxyvitamin D (25(OH)D) (the standard biomarker for vitamin D status) can have multiple impacts on the cardiovascular system. The aim of the study was to assess of the influence of 25(OH)D on severity of coronary atherosclerosis and lipid profile....

10 October 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
EDEwelina A. Dziedzic
Ewelina A. Dziedzic
Jakub S. GąsiorJakub S. Gąsior
Jakub S. Gąsior
ATAgnieszka Tuzimek
Agnieszka Tuzimek
MDMarek Jerzy Dąbrowski
Marek Jerzy Dąbrowski
PJPiotr Jankowski
Piotr Jankowski
The incidence of ischemic heart disease (IHD) increases every year. This cardiovascular disease has an inflammatory factor in its etiology due to different immune cells that influence atherogenesis. New inflammatory biomarkers—the Systemic Inflammatory Index (SII) and the Systemic Inflammatory Response (SIRI)—attempt to describe the pro- and anti-inflammatory balance and quantify the complex impact of the immune system on atherosclerosis, while vitamin D has a multidirectional impact on the human body, including the cardiovascular and immune systems. Hence, the objective of this research was to analyze the association between SII and SIRI and serum vitamin D concentrations in patients with IHD. A significant correlation was observed between SIRI and 25(OH)D in the whole group and between both biomarkers (SII and SIRI) and 25(OH)D in the group of patients with ACS but not in the group of patients with stable IHD. The role of vitamin D in IHD complications and its association with new inflammatory biomarkers requires further well-designed, large-scale research.

11 July 2018 in International Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
APAgata Popielarz-Grygalewicz
Agata Popielarz-Grygalewicz
Jakub S. GąsiorJakub S. Gąsior
Jakub S. Gąsior
AKAleksandra Konwicka
Aleksandra Konwicka
PGPaweł Grygalewicz
Paweł Grygalewicz
MSMaria Stelmachowska-Banaś
Maria Stelmachowska-Banaś
MDMarek Jerzy Dąbrowski
Marek Jerzy Dąbrowski
To determine whether the echocardiographic presentation allows for diagnosis of acromegalic cardiomyopathy. 140 patients with acromegaly underwent echocardiography as part of routine diagnostics. The results were compared with the control group comprising of 52 age- and sex-matched healthy volunteers. Patients with acromegaly presented with higher BMI, prevalence of arterial hypertension, and glucose metabolism disorders (i.e., diabetes and/or prediabetes). In patients with acromegaly, the following findings were detected: increased left atrial volume index, increased interventricular septum thickness, increased posterior wall thickness, and increased left ventricular mass index, accompanied by reduced diastolic function measured by the following parameters: E’med., E/E’, and E/A. Additionally, they presented with abnormal right ventricular systolic pressure. All patients had normal systolic function measured by ejection fraction. However, the values of global longitudinal strain were slightly lower in patients than in the control group; the difference was statistically significant. There were no statistically significant differences in the size of the right and left ventricle, thickness of the right ventricular free wall, and indexed diameter of the ascending aorta between patients with acromegaly and healthy volunteers. None of 140 patients presented systolic dysfunction, which is the last phase of the so-called acromegalic cardiomyopathy. Some abnormal echocardiographic parameters found in acromegalic patients may be caused by concomitant diseases and not elevated levels of GH or IGF-1 alone. The potential role of demographic parameters like age, sex, and/or BMI requires further research.

1 July 2022 in Biology
Verified
Journal Article
Open access
PDF file
EDEwelina A. Dziedzic
Ewelina A. Dziedzic
Jakub S. GąsiorJakub S. Gąsior
Jakub S. Gąsior
ATAgnieszka Tuzimek
Agnieszka Tuzimek
MDMarek Jerzy Dąbrowski
Marek Jerzy Dąbrowski
PJPiotr Jankowski
Piotr Jankowski
Coronary artery disease (CAD), the leading cause of death worldwide, has an underlying cause in atherosclerosis. The activity of this inflammatory process can be measured with neutrophil-to-lymphocyte ratio (NLR). The anti-inflammatory and anti-atherogenic properties of vitamin D affect many mechanisms involved in CAD. In this study, we investigated the association between NLR, vitamin D concentration, and severity of CAD in a group of patients with a history of myocardial infarction (MI). NLR was higher in patients with acute coronary syndrome (ACS) in comparison to those with stable CAD (median: 2.8, range: 0.96–24.3 vs. median: 2.3, range: 0.03–31.6; p < 0.05). No associations between NLR and severity of CAD (p = 0.14) in the cohort and in the subgroups with stable CAD (p = 0.40) and ACS (p = 0.34) were observed. We found no correlation between vitamin D level and NLR neither in the whole study group (p = 0.29) nor in subgroups of patients with stable CAD (p = 0.84) and ACS (p = 0.30). NLR could be used as prognostic biomarker of consecutive MI in patients with CAD and a history of MI.

5 November 2021 in Biology
Verified
Journal Article
Open access
PDF file
EDEwelina A. Dziedzic
Ewelina A. Dziedzic
WSWiktor Smyk
Wiktor Smyk
ISIzabela Sowińska
Izabela Sowińska
MDMarek Jerzy Dąbrowski
Marek Jerzy Dąbrowski
PJPiotr Jankowski
Piotr Jankowski
Background: Postmenopausal women experience rapid progression of coronary artery disease. Vitamin D deficiency appears to be a modifiable risk factor for cardiovascular diseases. This study aimed to analyze the impact of 25-hydroxyvitamin D3 (25(OH)D) level on the severity of coronary atherosclerosis and its potential cardioprotective effect in postmenopausal women. Material and Methods: The study prospectively recruited 351 women in postmenopausal age undergoing coronary angiography. The severity of coronary atherosclerosis was assessed using the Coronary Artery Surgery Study Score (CASSS). A level of 25(OH)D was measured with electrochemiluminescence. Results: Women with more severe coronary atherosclerosis have significantly lower 25(OH)D serum level (p = 0.0001). Vitamin D (β = −0.02; p = 0.016), hypertension (β = 0.44; p = 0.025), age (β = 0.02; p = 0.003), and history of MI (β = 0.63; p < 0.0001), were shown as CASSS determinants. Age, hyperlipidemia, and history of MI were found to determine the level of vitamin D (all p < 0.05). Women with a three-vessel disease hospitalized due to ACS, with a history of MI, hyperlipidemia and hypertension presented the lowest vitamin D level. Conclusions: Our study showed that lower serum 25(OH)D in postmenopausal women is associated with more significant stenosis in the coronary arteries. Therefore, we suggest considering low vitamin D level as a potential risk factor for coronary artery disease.